Viewing Study NCT05186558


Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2025-12-25 @ 10:04 PM
Study NCT ID: NCT05186558
Status: NOT_YET_RECRUITING
Last Update Posted: 2022-03-07
First Post: 2021-12-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module